Nanexa has entered into a licence and option agreement with [...]

Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

Nanexa has received approval for a Japanese patent covering a [...]

The collaboration, Nanexa says, provides further proof that PharmaShell atomic [...]

Gilead Sciences has received a positive opinion from the Committee [...]

Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]